• Renner K, Bruss C, Schnell A, Koehl G, Becker HM, Fante M, Menevse AN, Kauer N, Blazquez R, Hacker L, Decking SM, Bohn T, Faerber S, Evert K, Aigle L, Amslinger S, Landa M, Krijgsman O, Rozeman EA, Brummer C, Siska PJ, Singer K, Pektor S, Miederer M, Peter K, Gottfried E, Herr W, Marchiq I, Pouyssegur J, Roush WR, Ong S, Warren S, Pukrop T, Beckhove P, Lang SA, Bopp T, Blank CU, Cleveland JL, Oefner PJ, Dettmer K, Selby M, Kreutz M., Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy., Cell Rep. 2019 Oct 1; 29(1):135-150.e9. doi: 10.1016/j.celrep.2019.08.068.
  • Yao C, Sun H, Ji Y, Moseman EA, Shih HY, Heuston EF, Lacey NE, Kirby M, Anderson S, Cheng J, Fioravanti J, Hu J, Handon R, Reilley J, Gossa S, Gattinoni L, McGavern DB, O’Shea JJ, Schwartzberg PL, Wu T. Single-Cell Transcriptomics Identifies TOX as a Key Transcriptional Regulator of Stem-Like CD8+ T Cells in Chronic Infection. Nat Immunol. 2019 Jul; 20(7):890-901. doi: 10.1038/s41590-019-0403-4. Epub 2019 Jun 17.
  • Hamdane N, Jühling F, Crouchet E, El Saghire H, Thumann C, Oudot MA, Bandiera S, Saviano A, Ponsolles C, Roca Suarez AA, Li S, Fujiwara N, Ono A, Davidson I, Bardeesy N, Schmidl C, Bock C, Schuster C, Lupberger J, Habersetzer F, Doffoël M, Piardi T, Sommacale D, Imamura M, Uchida T, Ohdan H, Aikata H, Chayama K, Boldanova T, Pessaux P, Fuchs BC, Hoshida Y, Zeisel MB, Duong FHT, Baumert TF., HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response., Gastroenterology. 2019 Jun; 156(8):2313-2329.e7. doi: 10.1053/j.gastro.2019.02.038. Epub 2019 Mar 2.
  • Michel C, Burchert A, Hochhaus A, Saussele S, Neubauer A, Lauseker M, Krause SW, Kolb HJ, Hossfeld DK, Nerl C, Baerlocher GM, Heim D, Brümmendorf TH, Fabarius A, Haferlach C, Schlegelberger B, Balleisen L, Goebeler ME, Hänel M, Ho A, Dengler J, Falge C, Möhle R, Kremers S, Kneba M, Stegelmann F, Köhne CH, Lindemann HW, Waller CF, Spiekermann K, Berdel WE, Müller L, Edinger M, Mayer J, Beelen DW, Bentz M, Link H, Hertenstein B, Fuchs R, Wernli M, Schlegel F, Schlag R, de Wit M, Trümper L, Hebart H, Hahn M, Thomalla J, Scheid C, Schafhausen P, Verbeek W, Eckart MJ, Gassmann W, Schenk M, Brossart P, Wündisch T, Geer T, Bildat S, Schäfer E, Hasford J, Hehlmann R, Pfirrmann M., Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV., Haematologica. 2018 Dec 4. pii: haematol.2018.206797. doi: 10.3324/haematol.2018.206797. Haematologica. 2019 May; 104(5):955-962. doi: 10.3324/haematol.2018.206797. Epub 2018 Dec 4.
  • Ji Y, Fioravanti J, Zhu W, Wang H, Wu T, Hu J, Lacey NE, Gautam S, Le Gall JB, Yang X, Hocker JD, Escobar TM, He S, Dell'Orso S, Hawk NV, Kapoor V, Telford WG, Di Croce L, Muljo SA, Zhang Y, Sartorelli V, Gattinoni L., miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8+ T cell fate., Nat Commun. 2019 May 14; 10(1):2157. doi: 10.1038/s41467-019-09882-8.
  • Delacher M, Schmidl C, Herzig Y, Breloer M, Hartmann W, Brunk F, Kägebein D, Träger U, Hofer AC, Bittner S, Weichenhan D, Imbusch CD, Hotz-Wagenblatt A, Hielscher T, Breiling A, Federico G, Gröne HJ, Schmid RM, Rehli M, Abramson J, Feuerer M., Rbpj expression in regulatory T cells is critical for restraining TH2 responses., Nat Commun. 2019 Apr 8; 10(1):1621. doi: 10.1038/s41467-019-09276-w.
  • Gautam S, Fioravanti J, Zhu W, Le Gall JB, Brohawn P, Lacey NE, Hu J, Hocker JD, Voong N, Kapoor V, Telford WG, Gurusamy D, Yu Z, Bhandoola A, Xue HH, Roychoudhuri R, Higgs BW, Restifo NP, Bender TP, Ji Y, Gattinoni L. The transcription factor c-Myb enhances CD8+ T cell stemness and antitumor immunity. Nat Immunol. 2019 Mar; 20(3):337-349. doi: 10.1038/s41590-018-0311-z. Epub 2019 Feb 18.
  • Schmidl C, Vladimer GI, Rendeiro AF, Schnabl S, Krausgruber T, Taubert C, Krall N, Pemovska T, Araghi M, Snijder B, Hubmann R, Ringler A, Runggatscher K, Demirtas D, de la Fuente OL, Hilgarth M, Skrabs C, Porpaczy E, Gruber M, Hoermann G, Kubicek S, Staber PB, Shehata M, Superti-Furga G, Jäger U, Bock C., Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL., Nat Chem Biol. 2019 Mar; 15(3):232-240. doi: 10.1038/s41589-018-0205-2. Epub 2019 Jan 28.
  • H. Hoffmeister, A. Fuchs, L. Strobl, F. Sprenger, R. Gröbner-Ferreira, S. Michaelis, P. Hoffmann, J. Nazet, R. Merkl, and G. Längst (2019) Elucidation of the functional roles of the Q and I motifs in the human chromatin-remodeling enzyme BRG1., J Biol Chem. 2019 Mar 1;294(9):3294-3310. doi: 10.1074/jbc.RA118.005685. Epub 2019 Jan 15.
  • Yamamoto TN, Lee PH, Vodnala SK, Gurusamy D, Kishton R, Yu Z, Eidizadeh A, Eil R, Fioravanti J, Gattinoni L, Kochenderfer JN, Fry TJ, Aksoy BA, Hammerbacher J, Cruz AC, Siegel R, Restifo NP, Klebanoff CA. T cells engineered to overcome death signaling within the tumor microenvironment enhance adoptive cancer immunotherapy. J Clin Invest. 2019 Feb 25;129(4):1551-1565. doi: 10.1172/JCI121491. eCollection 2019 Feb 25.
  • Schulz D, Stancev I, Sorrentino A, Menevse AN, Beckhove P, Brockhoff G, Hautmann MG, Reichert TE, Bauer RJ, Ettl T.; Increased PD-L1 expression in radioresistant HNSCC cell lines after irradiation affects cell proliferation due to inactivation of GSK-3beta., Oncotarget. 2019 Jan 15;10 (5):573-583. doi: 10.18632/oncotarget.26542. eCollection 2019 Jan 15.
Anfahrt